300 related articles for article (PubMed ID: 8643566)
1. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
[TBL] [Abstract][Full Text] [Related]
2. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS.
Ravichandran KS; Lorenz U; Shoelson SE; Burakoff SJ
Mol Cell Biol; 1995 Feb; 15(2):593-600. PubMed ID: 7529871
[TBL] [Abstract][Full Text] [Related]
4. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation.
Ravichandran KS; Burakoff SJ
J Biol Chem; 1994 Jan; 269(3):1599-602. PubMed ID: 8294403
[TBL] [Abstract][Full Text] [Related]
5. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 1998 Nov; 161(9):4627-33. PubMed ID: 9794391
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
7. The shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3.
Velazquez L; Gish GD; van Der Geer P; Taylor L; Shulman J; Pawson T
Blood; 2000 Jul; 96(1):132-8. PubMed ID: 10891441
[TBL] [Abstract][Full Text] [Related]
8. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
9. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association.
Evans GA; Goldsmith MA; Johnston JA; Xu W; Weiler SR; Erwin R; Howard OM; Abraham RT; O'Shea JJ; Greene WC
J Biol Chem; 1995 Dec; 270(48):28858-63. PubMed ID: 7499411
[TBL] [Abstract][Full Text] [Related]
10. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.
Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW
J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373
[TBL] [Abstract][Full Text] [Related]
11. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
[TBL] [Abstract][Full Text] [Related]
12. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
Delespine-Carmagnat M; Bouvier G; Bertoglio J
Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a physical association between the Shc-PTB domain and the beta c chain of the granulocyte-macrophage colony-stimulating factor receptor.
Pratt JC; Weiss M; Sieff CA; Shoelson SE; Burakoff SJ; Ravichandran KS
J Biol Chem; 1996 May; 271(21):12137-40. PubMed ID: 8647804
[TBL] [Abstract][Full Text] [Related]
14. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.
Trüb T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE
J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo.
Ravichandran KS; Zhou MM; Pratt JC; Harlan JE; Walk SF; Fesik SW; Burakoff SJ
Mol Cell Biol; 1997 Sep; 17(9):5540-9. PubMed ID: 9271429
[TBL] [Abstract][Full Text] [Related]
16. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
17. Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP.
Lamkin TD; Walk SF; Liu L; Damen JE; Krystal G; Ravichandran KS
J Biol Chem; 1997 Apr; 272(16):10396-401. PubMed ID: 9099679
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of the beta 4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes.
Dans M; Gagnoux-Palacios L; Blaikie P; Klein S; Mariotti A; Giancotti FG
J Biol Chem; 2001 Jan; 276(2):1494-502. PubMed ID: 11044453
[TBL] [Abstract][Full Text] [Related]
19. Shc associates with the IL-3 receptor beta subunit, SHIP and Gab2 following IL-3 stimulation. Contribution of Shc PTB and SH2 domains.
Bone H; Welham MJ
Cell Signal; 2000 Mar; 12(3):183-94. PubMed ID: 10704825
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
